Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
29.40
+0.37 (1.27%)
Apr 19, 2024, 4:00 PM EDT - Market closed

HRMY Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Net Income
128.85181.4734.6-63.85-187.21-70.08
Depreciation & Amortization
24.3623.3918.8410.243.210.18
Share-Based Compensation
31.2126.9116.115.199.911.08
Other Operating Activities
34.97-87.2929.0218.5363.42-0.16
Operating Cash Flow
219.39144.4798.56-2.99-75.44-38.8
Operating Cash Flow Growth
51.86%46.58%----
Capital Expenditures
-0.31-0.17-0.3-0-0.15-1.34
Acquisitions
-36.97-40-100-2-1270
Change in Investments
-9.16-101.660000
Investing Cash Flow
-46.44-141.83-100.3-2-127.15-1.34
Share Issuance / Repurchase
-94.958.8439.07147.760.09-3.2
Debt Issued / Paid
-10.09-2-31.6573.6194.820
Other Financing Activities
-0.51---12.2148.8724.82
Financing Cash Flow
-105.556.847.42209.16143.7721.62
Net Cash Flow
67.49.485.68204.17-58.82-18.53
Free Cash Flow
219.08144.2998.26-2.99-75.59-40.14
Free Cash Flow Growth
51.83%46.85%----
Free Cash Flow Margin
37.64%32.95%32.17%-1.87%-1260.80%-
Free Cash Flow Per Share
3.682.441.71-0.12-9.72-4.53
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).